Webinar: Affiliate Based Outsourcing for Regulatory Affairs
Affiliate based Outsourcing Model for Regulatory Affairs works as a replacement or an extension of the company’s internal and local RA resources. Many challenges come up from managing your RA activities as sometimes their processes are not harmonized across different countries, the resources are not cost-optimized or simply there isn’t enough of them.
Thus, the purpose of this webinar is to share practical tips and insights on the effective optimization of local regulatory affairs setup, management and relevant costs.
You will learn about:
- Advantages of ABO model with regards to Governance, Workload, Quality and Cost optimization.
- Practical Tips for project setup, management, oversight and methodology.
- Collaboration map between client and provider.
Expanding Your Geographical Reach?
Make use of our experience to expand across Europe. Explore your options in an informal chat with one of our experts.
Who Should Attend?
- Global and regional RA Managers
- Regulatory Strategy Managers
- RA Partnerships Operations Manager
- QA Managers supporting RA
- RA Healthcare Compliance Managers
Duration: 40 min.
Speakers:
- Head of Global Regulatory Affairs, Olga Bernardova;
- Head of Project Managers for Regulatory Affairs, Claudia Ghislieri.
Olga Bernardova, MSc
Head of Global Regulatory Affairs
Other content that might interest you:
CMC: Effective Writing Of IND And IMPD
This artical focuses on best practices in delivering an effective CMC writing strategy when writing an IND or IMPD.
Webinar: Effective IMPD Writing. The Quality Part
Effective IMPD writing, including the quality part is a vital document that contains information about an investigational medicinal product and it is an essential part of the Clinical Trial Application (CTA), which is required by competent authorities in EU. The...
Expediting access through Reliance Pathways: MENA region
Reliance models are review pathways used by Regulators to expedite the patient access to essential pharmaceutical products and to overcome resource constraints and priorities. Recently, several National Competent Authorities (NCA) in the Middle East North Africa (MENA) region have implemented the Abridged and Verification reviews. These regulatory procedures allow the approvement of needed innovative and/or life-saving drugs.
